Literature DB >> 21321392

Three postulates to help identify the cause of Alzheimer's disease.

Jack C de la Torre1.   

Abstract

Two centuries ago, the German bacteriologist Robert Koch proposed three postulates to support a causal relationship between a specific microbe and an infectious disease. Similarly, three postulates are formulated here to help evaluate hypothetical proposals attempting to explain the pathogenesis of Alzheimer's disease (AD). The first postulate requires that the cause of AD precedes the cognitive decline and neurodegenerative pathology that characterize AD. This rule identifies a primary event from a neuropathological effect generated by the disease process. The second postulate stipulates that interventions aimed at the proposed causal event should prevent or reverse the cognitive and neurodegenerative pathology associated with AD prior to disease onset. This postulate emphasizes prevention or reversal of emerging neurocognitive pathology considerably before AD onset. If the first and second postulate requirements are met, the third postulate follows that interventions targeting the causal event should significantly lower the incidence of AD. For a causal hypothesis to be considered "likely" pathogenic to AD, support from all three postulates is a requisite. The pragmatic potential of the three postulates was applied to seven proposals using evidence-based meta-analysis mainly from randomized controlled trials. Proposals included the amyloid-β, cell cycle, cholinergic, inflammatory, oxidative stress, tau, and vascular hypotheses. Clinical evidence derived from each proposal formed the basis for an inferential conclusion based on the level of confidence provided by the trial data. The three postulates may challenge or help validate a proposed cause-effect relationship to AD and serve as a useful model for designing more intelligent therapeutic interventions aimed at preventing AD.

Entities:  

Mesh:

Year:  2011        PMID: 21321392     DOI: 10.3233/JAD-2011-101884

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  6 in total

Review 1.  Neuronal AChE splice variants and their non-hydrolytic functions: redefining a target of AChE inhibitors?

Authors:  M Zimmermann
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

Review 2.  Raf kinase inhibitory protein (RKIP): functional pleiotropy in the mammalian brain.

Authors:  Harrod H Ling; Lucia Mendoza-Viveros; Neel Mehta; Hai-Ying M Cheng
Journal:  Crit Rev Oncog       Date:  2014

3.  Early mitochondrial dysfunction leads to altered redox chemistry underlying pathogenesis of TPI deficiency.

Authors:  Stacy L Hrizo; Isaac J Fisher; Daniel R Long; Joshua A Hutton; Zhaohui Liu; Michael J Palladino
Journal:  Neurobiol Dis       Date:  2013-01-12       Impact factor: 5.996

4.  Clinico-pathological correlations of the most common neurodegenerative dementias.

Authors:  Ricardo Taipa; João Pinho; Manuel Melo-Pires
Journal:  Front Neurol       Date:  2012-05-01       Impact factor: 4.003

5.  Patients and agents - or why we need a different narrative: a philosophical analysis.

Authors:  Harald Walach; Michael Loughlin
Journal:  Philos Ethics Humanit Med       Date:  2018-10-14       Impact factor: 2.464

6.  Computational modeling of the effects of amyloid-beta on release probability at hippocampal synapses.

Authors:  Armando Romani; Cristina Marchetti; Daniela Bianchi; Xavier Leinekugel; Panayiota Poirazi; Michele Migliore; Hélène Marie
Journal:  Front Comput Neurosci       Date:  2013-01-25       Impact factor: 2.380

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.